Literature DB >> 18310762

Expression of hypoxia-inducible factor-1alpha and its relationship to tumour angiogenesis and cell proliferation in cartilage tumours.

T Kubo1, T Sugita, S Shimose, T Matsuo, K Arihiro, M Ochi.   

Abstract

We investigated the use of hypoxia-inducible factor (HIF) proteins as prognostic markers in chondrosarcoma and the relationship of HIF to the biological characteristics of cartilage tumours. The expression of HIF-1alpha, HIF-2alpha, proliferating cell nuclear antigen (PCNA) and microvessel density (MVD) were measured immunohistochemically in 29 specimens of cartilage tumour. There was no HIF-1alpha and HIF-2alpha staining in any of the nine benign cartilage tumours. In 20 specimens of chondrosarcoma, the rate of HIF-1alpha and HIF-2alpha expression was 40% and 25%, respectively. The tumour size (> or = 8 cm), histological grade (grade 2 and grade 3) surgical margin (marginal and intralesional) and HIF-1alpha expression (positive) correlated significantly with a shorter disease-free survival. There was a significant association between HIF-1alpha and the MVD and a strong trend towards a correlation between HIF-1alpha and the PCNA index or histological grade. Our findings suggest that HIF-1alpha protein may be a useful objective marker in the assessment of the prognosis in chondrosarcoma, since it plays an important role in tumour angiogenesis and cell proliferation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18310762     DOI: 10.1302/0301-620X.90B3.19806

Source DB:  PubMed          Journal:  J Bone Joint Surg Br        ISSN: 0301-620X


  20 in total

Review 1.  Cartilage tumours and bone development: molecular pathology and possible therapeutic targets.

Authors:  Judith V M G Bovée; Pancras C W Hogendoorn; Jay S Wunder; Benjamin A Alman
Journal:  Nat Rev Cancer       Date:  2010-06-10       Impact factor: 60.716

Review 2.  Therapeutic molecular targets in human chondrosarcoma.

Authors:  Nuor Jamil; Sarah Howie; Donald M Salter
Journal:  Int J Exp Pathol       Date:  2010-10       Impact factor: 1.925

3.  Hypoxia induces Wee1 expression and attenuates hydrogen peroxide-induced endothelial damage in MS1 cells.

Authors:  Ki Sun Hong; Hyeon Soo Kim; Se Hoon Kim; Dong Jun Lim; Jung Yul Park; Sang Dae Kim
Journal:  Exp Mol Med       Date:  2011-12-31       Impact factor: 8.718

Review 4.  Hypoxia, stem cells and bone tumor.

Authors:  Wen Zeng; Rong Wan; Yuehuan Zheng; Shree Ram Singh; Yiyong Wei
Journal:  Cancer Lett       Date:  2011-09-29       Impact factor: 8.679

5.  miR-181a Targets RGS16 to Promote Chondrosarcoma Growth, Angiogenesis, and Metastasis.

Authors:  Xiaojuan Sun; Cherie Charbonneau; Lei Wei; Qian Chen; Richard M Terek
Journal:  Mol Cancer Res       Date:  2015-05-26       Impact factor: 5.852

6.  Role and mechanism of hypoxia-inducible factor-1 in cell growth and apoptosis of breast cancer cell line MDA-MB-231.

Authors:  Yonghong Shi; Miaomiao Chang; Fang Wang; Xiaohui Ouyang; Yongfeng Jia; Hua DU
Journal:  Oncol Lett       Date:  2010-07-01       Impact factor: 2.967

7.  Surmounting chemotherapy and radioresistance in chondrosarcoma: molecular mechanisms and therapeutic targets.

Authors:  Anne C Onishi; Alexander M Hincker; Francis Y Lee
Journal:  Sarcoma       Date:  2010-12-30

8.  Hypoxia and hypoglycaemia in Ewing's sarcoma and osteosarcoma: regulation and phenotypic effects of Hypoxia-Inducible Factor.

Authors:  Helen J Knowles; Karl-Ludwig Schaefer; Uta Dirksen; Nicholas A Athanasou
Journal:  BMC Cancer       Date:  2010-07-16       Impact factor: 4.430

9.  The Bone Niche of Chondrosarcoma: A Sanctuary for Drug Resistance, Tumour Growth and also a Source of New Therapeutic Targets.

Authors:  E David; F Blanchard; M F Heymann; G De Pinieux; F Gouin; F Rédini; D Heymann
Journal:  Sarcoma       Date:  2011-05-22

10.  Tumor Suppressive Role of miR-342-5p in Human Chondrosarcoma Cells and 3D Organoids.

Authors:  Clément Veys; Abderrahim Benmoussa; Romain Contentin; Amandine Duchemin; Emilie Brotin; Jérôme E Lafont; Yannick Saintigny; Laurent Poulain; Christophe Denoyelle; Magali Demoor; Florence Legendre; Philippe Galéra
Journal:  Int J Mol Sci       Date:  2021-05-25       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.